• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,243.34 -116.67
( -0.16%)
Global Indices
Nasdaq
51,098.17 -484.76
(-0.94%)
Dow Jones
7,440.28 -165.03
(-2.17%)
Hang Seng
66,711.59 -759.10
(-1.13%)
Nikkei 225
10,374.30 13.98
(0.13%)
Forex
USD-INR
95.73 0.01
(0.01%)
EUR-INR
111.21 0.07
(0.06%)
GBP-INR
128.58 -0.06
(-0.05%)
JPY-INR
0.60 0.00
(0.01%)

EQUITY - MARKET SCREENER

Laurus Labs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
540222
INE947Q01028
97.214696
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LAURUSLABS
105.54
78174.11
EPS(TTM)
Face Value()
Div & Yield %
13.71
2
0.08
 

dmcc speciality chemicals ltd
Belding India reports consolidated net loss of Rs 4.65 crore in the March 2026 quarter
May 23,2026
Net Loss of Belding India reported to Rs 4.65 crore in the quarter ended March 2026 as against net loss of Rs 0.13 crore during the previous quarter ended March 2025. Sales reported to Rs 0.03 crore in the quarter ended March 2026. There were no Sales reported during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 3.55 crore in the year ended March 2026 as against net profit of Rs 0.24 crore during the previous year ended March 2025. Sales declined 99.86% to Rs 0.03 crore in the year ended March 2026 as against Rs 21.16 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.030 0 0.0321.16 -100
OPM %600.000 --2600.002.55 -
PBDT4.500 0 3.700.46 704
PBT3.000 0 1.600.33 385
NP-4.65-0.13 -3477 -3.550.24 PL